1 active not recruiting, 1 terminated. 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Memantine XR: new trials by email Literature Review of Memantine XR trials Research Report on Memantine XR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia Galantamine ER, Memantine XR - Schizophrenia, Schizoaffective Disorder | Phase 2 | Terminated | Sheppard Pratt Health System | 3 | 2014-09-01 | 2017-11-09 |
| Memantine for Enhanced Stroke Recovery Memantine XR, Placebo (for memantine) - Ischemic Stroke, Upper Extremity Weakness | Early Phase 1 | Active not recruiting | University of Utah | 20 | 2014-01-01 | 2026-08-27 |
Cognitive Dysfunction (1) · Ischemic Stroke (1) · Paresis (1) · Psychotic Disorders (1) · Schizophrenia (1)
Sheppard Pratt Health System (1) · University of Utah (1)
United States (2)
Alicia Bennett, D.O. (1) · Jennifer Majersik, M.D. (1) · Maju M. Koola, MD (1)